Health Care & Life Sciences

St. Francis hospitals getting Franciscan Alliance name

November 22, 2010
J.K. Wall
The Mishawaka-based health system's move comes after months of consumer research—and six months after rival system Clarian Health said it would change its name to Indiana University Health.
More

Dow AgroSciences moves into new research facility

November 20, 2010
 IBJ Staff
The division of Dow Chemical has a 15-year lease with Indianapolis-based developer Browning Investments on the two-story building near West 96th Street.
More

Community, Westview hospitals in 'strategic alliance' talks

November 18, 2010
J.K. Wall
The form an alliance would take is not clear, but Westview looked for additional resources from city's four major hospital systems.
More

City approves Beckman Coulter tax abatement

November 17, 2010
The tax abatement is tied to an expansion in which the company plans to invest $18 million in its Indianapolis operations and add as many as 95 jobs in the next three years.
More

Lilly scores series of small victories

November 17, 2010
J.K. Wall
The Indianapolis-based drugmaker finally won FDA approval for its antidepressant Cymbalta to treat chronic pain and fended off a patent challenge to rising-star cancer drug Alimta, but got a ratings downgrade on its debt.
More

Q&A

November 17, 2010
J.K. Wall
Les Zwirn, executive director of Better Healthcare for Indiana, talked about his group’s progress on promoting community collaborations to improve health and reduce the cost of care in cities around Indiana. BHI is hosting its third health care summit of Indiana community leaders today at Second Presbyterian Church in Indianapolis.
More

Court upholds Lilly patent on cancer drug Alimta

November 16, 2010
 IBJ Staff and Associated Press
A U.S. District Court judge on Monday upheld Eli Lilly and Co.’s patent on the cancer drug Alimta, protecting the compound until July 2016. It was a welcome win after a difficult few months for Indianapolis-based Lilly, which is facing a wave of patent expirations in coming years.
More

Study: Arthritis drug co-developed by Lilly shows promise

November 12, 2010
 IBJ Staff and Bloomberg News
Lilly paid $90 million in 2009 to acquire the global rights to the treatment in a bid to beef up its pipeline of medications for autoimmune diseases.
More

Acquisition big step for Lilly Diagnostics

November 10, 2010
J.K. Wall
Eli Lilly and Co.’s $800 million acquisition of Avid Radiopharmaceuticals Inc. is the biggest step yet in the drugmaker’s attempt to add diagnostics to its product portfolio.
More

Nurse practitioners get some autonomy

November 10, 2010
J.K. Wall
Could nurse practitioners get a promotion in the medical field? At least one health insurer is treating them like doctors now.
More

Drugmaker restarts race to boost 'good' cholesterol

November 10, 2010
Bloomberg News
Merck & Co. is betting it can succeed where Pfizer Inc. failed, with a new type of drug to combat heart disease by raising good cholesterol levels. Indianapolis-based Eli Lilly and Co. is testing a similar pill.
More

Drama builds in suit over Hilbert mother-in-law's life policy

November 6, 2010
Kathleen McLaughlin
Businessman J.B. Carlson is in debt for $5.9 million, and he may have been the last person to see 74-year-old Suzy Tomlinson alive. Her $15 million life-insurance policy named him as the beneficiary.
More

Indiana life sciences upstarts tap health reform booty

November 6, 2010
 IBJ Staff
The federal legislation is roundly criticized at a BioCrossroads meeting, but some firms have found a silver lining.
More

Indiana health exchange may take page from Utah playbookRestricted Content

November 6, 2010
J.K. Wall
In Utah, employers can give each of their workers a specific amount of money to apply toward health insurance. The worker then can use that money to choose from the 66 plans in the health insurance exchange.
More

Lilly wins approval of antidepressant Cymbalta for pain

November 4, 2010
Bloomberg News
The Food and Drug Administration has cleared Cymbalta for musculoskeletal pain such as arthritis and chronic lower back conditions, which could mean another $500 million in annual sales for Lilly, an analyst estimates.
More

Seeking growth, Lilly dumps Singapore for China

November 3, 2010
J.K. Wall
After recently deciding to close a research center in Singapore, Indianapolis-based Eli Lilly and Co. has decided to open a diabetes research center in China in the second half of 2011, further ramping up the drugmaker's presence in the world's fastest-growing pharmaceutical market.
More

Q&A: Jim Hamilton

November 3, 2010
J.K. Wall
Jim Hamilton, an employee-benefits lawyer at Bose McKinney & Evans in Indianapolis, discussed the likelihood of a Republican-controlled U.S. House of Representatives changing or even outright repealing the health care reform law, formally known as the Patient Protection and Affordable Care Act.
More

WellPoint boosts third-quarter profit, raises forecast

November 3, 2010
J.K. Wall
The Indianapolis-based health insurer raised its full-year profit forecast by 20 cents per share, after lower-than-expected claims and lower administrative costs increased third-quarter profit by 1 percent.
More

CNO Financial Group profit beats analysts' expectations

November 2, 2010
J.K. Wall
Excluding investment and special charges, the Carmel-based life and health insurer on Tuesday reported a profit $47.1 million, down 13 percent from the same quarter a year ago, but still beat analysts' expectations.
More

Lilly to open diabetes research center in China

November 2, 2010
 IBJ Staff
Indianapolis-based Eli Lilly and Co. plans to open a diabetes research center in China, the drugmaker said Tuesday, citing the high incidence of the disease there.
More

Indiana's life sciences industry sees trouble ahead

October 30, 2010
Associated Press
Indiana's life sciences industry has weathered the recession relatively well, but Eli Lilly's struggles and tight capital markets could threaten the future.
More

BioCrossroads helping laid-off life sciences workers land safely

October 30, 2010
Chris O'Malley
Indiana firms have dismissed more than 1,400 life science workers over the last two years. Now BioCrossroads has launched a website that aims to keep that talent in the state.
More

Former IU tech-transfer chief: State isn't competitive enoughRestricted Content

October 30, 2010
Norm Heikens
Mark Long was president of the Indiana University Research & Technology Corp., which was responsible for the university’s tech transfer, before launching a consulting firm, Long Performance Advisors, in 2008.
More

Eli Lilly will have to beat odds to meet drug-rollout goals

October 30, 2010
J.K. Wall
Eli Lilly and Co. executives have said repeatedly that the company’s bulging pipeline will produce two new drugs per year, beginning in 2013. But only three times in the past six decades has Lilly been able to launch two or more new drugs in back-to-back years.
More

Indiana life sciences sector copes with shrinking VC poolRestricted Content

October 30, 2010
Chris O\'malley
Venture funds nationwide crested at $100 billion in 2000, but that number last year had drooped to $18 billion.
More
Page  << 61 62 63 64 65 66 67 68 69 70 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. How can any company that has the cash and other assets be allowed to simply foreclose and not pay the debt? Simon, pay the debt and sell the property yourself. Don't just stiff the bank with the loan and require them to find a buyer.

  2. If you only knew....

  3. The proposal is structured in such a way that a private company (who has competitors in the marketplace) has struck a deal to get "financing" through utility ratepayers via IPL. Competitors to BlueIndy are at disadvantage now. The story isn't "how green can we be" but how creative "financing" through captive ratepayers benefits a company whose proposal should sink or float in the competitive marketplace without customer funding. If it was a great idea there would be financing available. IBJ needs to be doing a story on the utility ratemaking piece of this (which is pretty complicated) but instead it suggests that folks are whining about paying for being green.

  4. The facts contained in your post make your position so much more credible than those based on sheer emotion. Thanks for enlightening us.

  5. Please consider a couple of economic realities: First, retail is more consolidated now than it was when malls like this were built. There used to be many department stores. Now, in essence, there is one--Macy's. Right off, you've eliminated the need for multiple anchor stores in malls. And in-line retailers have consolidated or folded or have stopped building new stores because so much of their business is now online. The Limited, for example, Next, malls are closing all over the country, even some of the former gems are now derelict.Times change. And finally, as the income level of any particular area declines, so do the retail offerings. Sad, but true.

ADVERTISEMENT